Dermatology Maui Derm Hawaii 2023: Expert Interview Dr. Melinda Gooderham — Length: 07:00 TYK2 Inhibition in the Management of Moderate-to-Severe Plaque Psoriasis Watch Presentation
Dermatology Maui Derm Hawaii 2023 January 23-27, 2023 — Maui, Hawaii New Oral Drug Class Highly Specific for Moderate-to-Severe Plaque Psoriasis Download 5 PowerPoint slides
rheumatology American College of Rheumatology (ACR) Convergence 2022: Expert Interview Dr. Tom Appleton — Length: 07:00 Head-to-head Trial Renews Emphasis on Radiographic Progression as a Therapeutic Goal in Axial Spondyloarthritis Watch Presentation
rheumatology American College of Rheumatology (ACR) Convergence 2022 November 10-14, 2022 — Philadelphia, Pennsylvania Biologics Attenuate Radiographic Progression over 2-Year Period in Patients with Axial Spondyloarthritis Download 4 PowerPoint slides
Dermatology European Academy of Dermatology and Venereology (EADV) 2022: Expert Interview Dr. Kim Papp — Length: 05:32 Landmark Trials Support Promising New Treatment for Patients with Hidradenitis Suppurativa Watch Presentation
Dermatology European Academy of Dermatology and Venereology (EADV) 2022 Congress September 7-10, 2022 — Milan, Italy Phase 3 Trials Promise Highly Effective Option for Hidradenitis Suppurativa Download 4 PowerPoint slides
rheumatology GRAPPA Annual Meeting and Trainee Symposium 2022 July 14-16, 2022 — Brooklyn, New York Advancements in Psoriatic Arthritis Management: Updated GRAPPA Treatment Recommendations Download 1 PowerPoint slides
Dermatology Plaque Psoriasis: Expert Interview Dr. Melinda Gooderham — Length: 06:18 PURE Registry: Efficacy and Safety of IL-17 Inhibitor in Moderate-to-Severe Psoriasis Watch Presentation
Dermatology Plaque Psoriasis: Expert Review and Commentary from Published Literature Dr. Melinda Gooderham & Dr. Simon Nigen PURE Registry: Impact of IL-17 Inhibitor Therapy in Plaque Psoriasis Download 4 PowerPoint slides
rheumatology American College of Rheumatology (ACR) Convergence 2021 November 5-9, 2021 — Virtual Meeting Latest Data on JAK Inhibitors Prove Promising in Ankylosing Spondylitis Download 4 PowerPoint slides
rheumatology American College of Rheumatology (ACR) Convergence 2021: Expert Interview Dr. Johannes Roth — Length: 07:49 JUNIPERA Trial: Efficacy & Safety of IL-17i in Pediatric Use Watch Presentation
rheumatology American College of Rheumatology (ACR) Convergence 2021 November 5-9, 2021 — Virtual Meeting IL-17 Inhibitor Demonstrates Efficacy in Pediatric Counterparts of nr-axSpA and PsA Download 4 PowerPoint slides